Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
Danny Hsu, President of THANZ, reposted from ITP Australia and New Zealand on LinkedIn:
”Burden of disease in ITP patients is more significant than we think!
Thanks to the I-WISh study by Nichola Cooper, an excellent insight into what ITP patients go through.”
Quoting ITP Australia and New Zealand‘s post:
”Fatigue in ITP: A symptom that demands attention.
The original I‑WISh study highlighted a critical gap: while patients consistently report fatigue as one of the most disruptive aspects of Immune Thrombocytopenia (ITP), it is often under‑recognised in clinical practice.
“Fatigue has impacted my work, relationships, and daily routine.”
Now, I‑WISh 2.0 results are being finalised — with Australia included — offering fresh insights into patient and physician perspectives worldwide.
For healthcare professionals, this is a call to action: fatigue is not secondary.
It is central to the patient experience and must be addressed with empathy and integrated care strategies.
Explore the findings.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear